{"id":"W4405181656","doi":"10.1158/1538-8514.cancerchem24-ia006","title":"Abstract IA006: Progress, pitfalls and promise: the journey to effective and well tolerated DNA damage response inhibitor combinations in the clinic","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"PARP inhibitor; Tolerability; Medicine; Cancer; DNA damage; Poly ADP ribose polymerase; Pharmacology; Cancer research; Polymerase; DNA; Adverse effect; Internal medicine; Chemistry; Biochemistry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00394409,0.000804629,0.0008464258,0.0009285104,0.0008306235,0.004756819,0.001042512,0.002404566,0.01808811],"category_scores_gemma":[0.002818823,0.0003756461,0.0004312178,0.0008246263,0.001577527,0.005532708,0.001337888,0.006333761,0.01032123],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002246576,"about_ca_system_score_gemma":0.002594331,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001033705,"about_ca_topic_score_gemma":0.003603077,"domain_scores_codex":[0.9987424,0.0003432597,0.00009649448,0.00009441358,0.0005925608,0.0001309583],"domain_scores_gemma":[0.9988018,0.0002722424,0.0001759047,0.00006966126,0.0003775086,0.0003028531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005277905,0.0002290678,0.0002928286,0.0009216112,0.00002509625,0.0002712237,0.0001525221,0.0003699237,0.008757873,0.02483496,0.5153264,0.4482907],"study_design_scores_gemma":[0.00008837171,0.0004933789,0.0004354411,0.0003785823,0.00001993223,0.0006374032,0.0001138216,0.0003229403,0.003015565,0.008110655,0.9863563,0.00002772811],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0053613,0.5807955,0.008352268,0.3096172,0.02114637,0.0001487199,0.0007867899,0.001012633,0.07277918],"genre_scores_gemma":[0.04550053,0.7148321,0.02287161,0.07940257,0.02155251,0.0002055517,0.001185919,0.0004582324,0.113991],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01808811,"threshold_uncertainty_score":0.06051075,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03213366642914434,"score_gpt":0.368427072439368,"score_spread":0.3362934060102237,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}